173 related articles for article (PubMed ID: 20874677)
1. Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.
Chan V; Fenning A; Iyer A; Hoey A; Brown L
Curr Pharm Biotechnol; 2011 Mar; 12(3):429-36. PubMed ID: 20874677
[TBL] [Abstract][Full Text] [Related]
2. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Chan V; Hoey A; Brown L
Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
[TBL] [Abstract][Full Text] [Related]
3. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
O'Brien D; Chunduri P; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
Allan A; Fenning A; Levick S; Hoey A; Brown L
Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Loch D; Levick S; Hoey A; Brown L
J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
Loch D; Hoey A; Brown L
Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
Mirkovic S; Seymour AM; Fenning A; Strachan A; Margolin SB; Taylor SM; Brown L
Br J Pharmacol; 2002 Feb; 135(4):961-8. PubMed ID: 11861324
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
9. Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt-Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats.
Yao NA; Niazi ZR; Najmanová I; Kamagaté M; Said A; Chabert P; Auger C; Die-Kakou H; Schini-Kerth V
J Cardiovasc Pharmacol; 2020 Jun; 75(6):573-583. PubMed ID: 32187164
[TBL] [Abstract][Full Text] [Related]
10. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
Brown L; Ooi SY; Lau K; Sernia C
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase.
Loch D; Hoey A; Morisseau C; Hammock BO; Brown L
Cell Biochem Biophys; 2007; 47(1):87-98. PubMed ID: 17406062
[TBL] [Abstract][Full Text] [Related]
12. l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats.
Fenning A; Harrison G; Rose'meyer R; Hoey A; Brown L
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1408-16. PubMed ID: 15923320
[TBL] [Abstract][Full Text] [Related]
13. Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats.
Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Shirataki H; Matsuoka H
J Hypertens; 2001 Apr; 19(4):795-801. PubMed ID: 11330883
[TBL] [Abstract][Full Text] [Related]
14. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
[TBL] [Abstract][Full Text] [Related]
16. Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Functional and Structural Changes.
Bal NB; Han S; Usanmaz SE; Kiremitci S; Sadi G; Uludag O; Demirel-Yilmaz E
J Cardiovasc Pharmacol; 2019 Aug; 74(2):105-117. PubMed ID: 31397742
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.
Iyer A; Fenning A; Lim J; Le GT; Reid RC; Halili MA; Fairlie DP; Brown L
Br J Pharmacol; 2010 Apr; 159(7):1408-17. PubMed ID: 20180942
[TBL] [Abstract][Full Text] [Related]
18. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
19. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
20. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.
Grobe JL; Mecca AP; Mao H; Katovich MJ
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2417-23. PubMed ID: 16415071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
